-
公开(公告)号：US20150190258A1
公开(公告)日：2015-07-09
申请号：US14660805
申请日：2015-03-17
IPC分类号： A61F5/00
CPC分类号： A61M29/00 , A61F5/0013 , A61F5/003 , A61F5/0036 , A61F5/0073 , A61F5/0076 , A61M25/10185
摘要： Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
摘要翻译： 提供了治疗肥胖症的装置和方法。 更具体地，提供了胃内装置及其制造，部署，充气，监测和检索方法。
-
公开(公告)号：US09011477B2
公开(公告)日：2015-04-21
申请号：US14270272
申请日：2014-05-05
CPC分类号： A61M29/00 , A61F5/0013 , A61F5/003 , A61F5/0036 , A61F5/0073 , A61F5/0076 , A61M25/10185
摘要： Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
-
公开(公告)号：US11219543B2
公开(公告)日：2022-01-11
申请号：US16414098
申请日：2019-05-16
发明人： Mark C. Brister , Nelson Quintana , Kaushik A. Patel , Neil R. Drake , Antonio C. Llevares , Dubravka Markovic , Andrew P. Rasdal , Amy D. L. VandenBerg
摘要： An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
-
公开(公告)号：US20200179147A1
公开(公告)日：2020-06-11
申请号：US16792094
申请日：2020-02-14
发明人： Mark C. Brister , Paul D. Faucher , Neil R. Drake , Andrew P. Rasdal , Matthew S. Lake , Dubravka Markovic , Amy D.L. VandenBerg , Antonio C. Llevares , Josefina Nider
摘要： Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
-
公开(公告)号：US10327936B2
公开(公告)日：2019-06-25
申请号：US15369599
申请日：2016-12-05
发明人： Mark C. Brister , Nelson Quintana , Kaushik A. Patel , Neil R. Drake , Antonio C. Llevares , Dubravka Markovic , Andrew P. Rasdal , Amy D. L. VandenBerg
摘要： An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
-
公开(公告)号：US09662239B2
公开(公告)日：2017-05-30
申请号：US15146832
申请日：2016-05-04
发明人： Mark C. Brister , Paul D. Faucher , Neil R. Drake , Andrew P. Rasdal , Matthew S. Lake , Dubravka Markovic , Amy D. L. VandenBerg , Antonio C. Llevares , Josefina Nider
CPC分类号： A61F5/003 , A61F5/0036 , A61F5/0089 , A61M25/10181 , A61M25/10185 , A61M29/02
摘要： Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
-
公开(公告)号：US20170079821A1
公开(公告)日：2017-03-23
申请号：US15369599
申请日：2016-12-05
发明人： Mark C. Brister , Nelson Quintana , Kaushik A. Patel , Neil R. Drake , Antonio C. Llevares , Dubravka Markovic , Andrew P. Rasdal , Amy D.L. VandenBerg
CPC分类号： A61F5/003 , A61B17/1204 , A61B17/12099 , A61B90/39 , A61B2090/3966 , A61F5/0036 , A61F5/0073 , A61F5/0083 , A61L31/088 , A61L31/10 , A61L2400/16 , A61L2420/02 , A61L2420/08 , A61M25/10185 , A61M25/1027 , A61M25/1029 , A61M31/002 , A61M2025/1031 , A61M2025/105 , Y10T156/1051
摘要： An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
-
公开(公告)号：US20170027728A1
公开(公告)日：2017-02-02
申请号：US15290977
申请日：2016-10-11
CPC分类号： A61M29/00 , A61F5/0013 , A61F5/003 , A61F5/0036 , A61F5/0073 , A61F5/0076 , A61M25/10185
摘要： Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
摘要翻译： 提供了治疗肥胖症的装置和方法。 更具体地，提供了胃内装置及其制造，部署，充气，监测和检索方法。
-
公开(公告)号：US09539132B2
公开(公告)日：2017-01-10
申请号：US14469442
申请日：2014-08-26
发明人： Mark C. Brister , Nelson Quintana , Kaushik A. Patel , Neil R. Drake , Antonio C. Llevares , Dubravka Markovic , Andrew P. Rasdal , Amy D.L. VandenBerg
CPC分类号： A61F5/003 , A61B17/1204 , A61B17/12099 , A61B90/39 , A61B2090/3966 , A61F5/0036 , A61F5/0073 , A61F5/0083 , A61L31/088 , A61L31/10 , A61L2400/16 , A61L2420/02 , A61L2420/08 , A61M25/10185 , A61M25/1027 , A61M25/1029 , A61M31/002 , A61M2025/1031 , A61M2025/105 , Y10T156/1051
摘要： An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
摘要翻译： 构造成用于由患者摄取的植入物。 在植入物被患者吞咽之后并且被放置在目标位置内，例如， 患者的胃，通气子部件导致植入物从紧凑的递送状态扩展到膨胀的体积占据部署状态。 在部署状态下，植入物在患者胃中产生饱腹感，从而有助于限制食物摄入和肥胖。 在预定时间之后，促使放气次级组件被移动并且植入物的尺寸减小，以便允许其通过病人消化道的其余部分。 该装置还可以包括跟踪和可视化子组件以及药物递送子组件。
-
公开(公告)号：US09468550B2
公开(公告)日：2016-10-18
申请号：US14660805
申请日：2015-03-17
IPC分类号： A61F5/00
CPC分类号： A61M29/00 , A61F5/0013 , A61F5/003 , A61F5/0036 , A61F5/0073 , A61F5/0076 , A61M25/10185
摘要： Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
-
-
-
-
-
-
-
-
-
搜索结果
38 条记录 (耗时 0.035 秒)
